Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("SINEMET")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

ANEMIE HEMOLYTIQUE AUTO-IMMUNE CHEZ UN PARKINSONIEN TRAITE PAR ASSOCIATION L. DOPA-CARBIDOPA.BARAT M; CONTE P; HILAIRE J et al.1977; BORDEAUX MED.; FR.; DA. 1977; VOL. 10; NO 18; PP. 1215-1217; BIBL. 15 REF.Article

SINEMET AND THE TREATMENT OF PARKINSONISMBOSHES B.1981; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1981; VOL. 94; NO 3; PP. 364-370; BIBL. 45 REF.Article

PARKINSON'S DISEASE: COGENTINR WITH SINEMETR: A BETTER RESPONSETOURTELLOTTE WW; POTVIN AR; SYNDULKO K et al.1982; PROG. NEURO-PSYCHOPHARMACOL. BIOL. PSYCHIATRY; ISSN 0278-5846; GBR; DA. 1982; VOL. 6; NO 1; PP. 51-55; BIBL. 20 REF.Article

Sinemet (CR4) : an open-label study in moderately severe Parkinson's diseaseMING, A; TEMLETT, J. A; FRITZ, V. U et al.Journal of internal medicine. 1991, Vol 230, Num 2, pp 113-117, issn 0954-6820Article

CARBIDOPA/LEVODOPA THERAPY OF COEXISTENT DRUG-INDUCED PARKINSONISM AND TARDIVE DYSKINESIASHOULSON I.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 259-266; BIBL. 23 REF.Article

SINEMET(REG.) AND THYROID FUNCTION IN PARKINSON DISEASEWINGERT TD; HERSHMAN JM.1979; NEUROLOGY; USA; DA. 1979; VOL. 29; NO 7; PP. 1073-1074; BIBL. 5 REF.Article

CARBIDOPA-LEVODOPATERAPIA (SINEMET) EN EL TRATAMIENTO DE ENFERMOS PARKINSONIANOS. RESULTADOS DE CUATRO ANOS DE TRATAMIENTO. = LA CARBIDOPA-LEVODOPATHERAPIE (SINEMET) DANS LE TRAITEMENT DES MALADES PARKINSONIENS. RESULTATS DE 4 ANS DE TRAITEMENTMARTINEZ LAGE JM; BURGUERA JA; DELGADO G et al.1978; ARCH. NEUROBIOL.; ESP; DA. 1978; VOL. 41; NO 1; PP. 3-18; ABS. ANGL.; BIBL. 36 REF.Article

HYPERTENSIVE CRISIS IN A PATIENT GIVEN SINEMET, METOCLOPRAMIDE, AND AMITRIPTYLINE.RAMPTON DS.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6087; PP. 607-608; BIBL. 4 REF.Article

ANEMIE HEMOLYTIQUE AUTO-IMMUNE CHEZ UN PARKINSONIEN TRAITE PAR ASSOCIATION L-DOPACARBIDOPA.BARAT M; CONTE P; HILAIRE J et al.1977; NOUV. PRESSE MED.; FR.; DA. 1977; VOL. 6; NO 27; PP. 2442; BIBL. 15 REF.Article

PARKINSON'S DISEASE TREATED WITH SINEMET OR MADOPAR. A CONTROLLED MULTICENTER TRIAL.PAKKENBERG H; BIRKET SMITH E; DUPONT E et al.1976; ACTA NEUROL. SCAND.; DANEM.; DA. 1976; VOL. 53; NO 5; PP. 376-385; BIBL. 5 REF.Article

L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuationsCEDARBAUM, J. M; TOY, L. H; GREEN-PARSONS, A et al.Clinical neuropharmacology. 1991, Vol 14, Num 3, pp 228-234, issn 0362-5664, 7 p.Article

Randomized double-blind cross-over study of sinemet-controlled release (CR4 50/200) versus sinemet 25/100 in Parkinson's diseaseLIEBERMAN, A; GOPINATHAN, G; MILLER, E et al.European neurology. 1990, Vol 30, Num 2, pp 75-78, issn 0014-3022, 4 p.Article

Comparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuationsJANKOVIC, J; SCHWARTZ, K; VANDER LINDEN, C et al.Movement disorders. 1989, Vol 4, Num 4, pp 303-309, issn 0885-3185Article

Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover studySAGE, J. I; MARK, M. H.Clinical neuropharmacology. 1988, Vol 11, Num 2, pp 174-179, issn 0362-5664Article

Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's diseaseNELSON, M. V; BERCHOU, R. C; LE WITT, P. A et al.Neurology. 1990, Vol 40, Num 1, pp 70-74, issn 0028-3878Article

Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with On-OffMCHALE, D. M; SAGE, J. I; SONSALLA, P. K et al.European neurology. 1990, Vol 30, Num 2, pp 90-92, issn 0014-3022, 3 p.Article

Acute overdose with controlled-release levodopa-carbidopaDELMAS, Gael; ROTHMANN, Christophe; FLESCH, Francoise et al.Clinical toxicology (Philadelphia, Pa. Print). 2008, Vol 46, Num 3, pp 274-277, issn 1556-3650, 4 p.Article

Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonistsGAGNON, C; BEDARD, P. J; DI PAOLO, T et al.European journal of pharmacology. 1990, Vol 178, Num 1, pp 115-120, issn 0014-2999Article

APPLICATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF LEVODOPA, CARBIDOPA, AND ENTACAPONE IN TABLET DOSAGE FORMSISSA, Yousry M; HASSOUN, Mohamed E. M; ZAYED, Ashraf G et al.Journal of liquid chromatography & related technologies. 2011, Vol 34, Num 17-20, pp 2433-2447, issn 1082-6076, 15 p.Article

  • Page / 1